Dermatitis Exfoliative (Exfoliative dermatitis) o se fa'ama'i fulafula o le paʻu, le mumu ma le ma'ema'e e a'afia ai le tino atoa. O lenei fa'aupuga e faʻaaogaina pe a afaina le 90% pe sili atu o le paʻu.
O le mafuaʻaga sili ona taatele o le erythroderma o le faʻateleina o se maʻi o le paʻu, e pei o le psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris, poʻo se maʻi vailaʻau, e pei o le faʻaaogaina o vailaʻau faʻamaʻi. O le fa'ata'ita'iga muamua e tau fa'ase'e ma e masani ona va'aia i le lymphoma T‑cell cutaneous. Ua taua le fa'avasegaina mai le lymphoma sela T o le paʻu, o le mea lea e faia se biopsy.
Erythroderma is an inflammatory skin disease with redness and scaling that affects nearly the entire cutaneous surface. This term applies when 90% or more of the skin is affected.
☆ AI Dermatology — Free Service I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
Red (burning) Skin Syndrome ― Erythema ma fua i le tino atoa o le faailoga autu o le Dermatitis Exfoliative (Exfoliative dermatitis).
Erythroderma o se ma'i e seasea ae tuga. E ui o le mafua'aga moni e masani ona le iloa, e mafai ona fa'aaosoina e se ma'i vaila'au po'o se kanesa faavae. O se tasi o kanesa masani e feso'ota'i ma le exfoliative dermatitis o le pa'u T-cell lymphoma, lea e ono le fa'aalia ni fa'ailoga mo ni masina po'o i tausaga talu ona amata le ma'i o le pa'u. E masani lava, e manaʻomia le falema'i mo su'esu'ega muamua ma togafitiga. O ma'i e maua i fa'ama'i fa'ama'i e masani lava ona iai se va'aiga lelei mo se taimi umi, e ui e mataupu e aunoa ma se mafua'aga manino e foliga mai e fa'aaauau pea ma toe fa'afo'i. Ole fa'asologa o ma'i e feso'ota'i i le kanesa e masani lava ona fa'alagolago i le alualu i luma o le kanesa. Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
E masani ona fa'aaalia le tele o le mumu ma le pa'u e ufiufi ai le 90% o le tino. O lenei tulaga o se fa'ailoga o le tele o fa'afitauli fa'alesoifua maloloina, e pei o le psoriasis, eczema, po'o se tali i nisi vaila'au. It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
O le mafuaʻaga sili ona taatele o le erythroderma o le faʻateleina o se maʻi o le paʻu, e pei o le psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris, poʻo se maʻi vailaʻau, e pei o le faʻaaogaina o vailaʻau faʻamaʻi. O le fa'ata'ita'iga muamua e tau fa'ase'e ma e masani ona va'aia i le lymphoma T‑cell cutaneous. Ua taua le fa'avasegaina mai le lymphoma sela T o le paʻu, o le mea lea e faia se biopsy.